Cargando…
Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients
INTRODUCTION: Only limited information exists on the pharmacokinetics of prolonged (> 24 hours) and high-dose dexmedetomidine infusions in critically ill patients. The aim of this study was to characterize the pharmacokinetics of long dexmedetomidine infusions and to assess the dose linearity of...
Autores principales: | Iirola, Timo, Aantaa, Riku, Laitio, Ruut, Kentala, Erkki, Lahtinen, Maria, Wighton, Andrew, Garratt, Chris, Ahtola-Sätilä, Tuula, Olkkola, Klaus T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334808/ https://www.ncbi.nlm.nih.gov/pubmed/22030215 http://dx.doi.org/10.1186/cc10518 |
Ejemplares similares
-
Pharmacokinetics of long-lasting, high-dose dexmedetomidine infusions in critically ill patients
por: Iirola, T, et al.
Publicado: (2011) -
Highly variable pharmacokinetics of dexmedetomidine during intensive care: a case report
por: Iirola, Timo, et al.
Publicado: (2010) -
Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients
por: Välitalo, Pyry Antti, et al.
Publicado: (2013) -
Predictive equations over-estimate the resting energy expenditure in amyotrophic lateral sclerosis patients who are dependent on invasive ventilation support
por: Siirala, Waltteri, et al.
Publicado: (2010) -
Is the effect of non-invasive ventilation on survival in amyotrophic lateral sclerosis age-dependent?
por: Siirala, Waltteri, et al.
Publicado: (2013)